Clear Street’s Aimei Health Technology Co AFJK Stock Holding History

Clear Street’s Portfolio AFJK Stock Details AFJK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Hold	83,337	–	–	﹤0.01%	452
2026 Q1	$948K	Hold	83,337	–	–	﹤0.01%	363
2025 Q4	$948K	Buy	83,337 +22,294	+37%	+$486K	﹤0.01%	300
2025 Q3	$691K	Buy	61,043 +21,518	+54%	+$242K	﹤0.01%	260
2025 Q2	$441K	Buy	39,525 +15,399	+64%	+$171K	﹤0.01%	173
2025 Q1	$265K	Sell	24,126 -1,023	-4%	-$11.1K	﹤0.01%	88
2024 Q4	$269K	Buy	25,149 +20,149	+403%	+$213K	﹤0.01%	87
2024 Q3	$52.4K	Sell	5,000 -50,525	-91%	-$527K	﹤0.01%	201
2024 Q2	$575K	Buy	+55,525	New	+$572K	0.01%	96

Other funds holding AFJK

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clear Street's AFJK Position: Q2 2026 in Review

Clear Street held its Aimei Health Technology Co (AFJK) position steady in Q2 2026 at 83,337 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Clear Street first reported a position in AFJK in Q2 2024 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold AFJK as of Q2 2026.

Clear Street held 83,337 shares of Aimei Health Technology Co worth $948K as of Q2 2026.
Clear Street left its Aimei Health Technology Co share count unchanged in Q2 2026.
Aimei Health Technology Co made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #452 holding.
Clear Street first reported a position in Aimei Health Technology Co in Q2 2024 and has held it in 9 quarters since.
7 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.